#USA #Healthcare Advisory #Mission 3A #Dr. Greg Berlet #Old Greenwich

Introduction

In an exciting development for the healthcare sector, Mission 3A Healthcare has officially launched its Healthcare Advisory Board, appointing prominent leaders from the industry. The newly formed board is expected to boost the company’s mission of transforming healthcare through innovative technologies and practices. The new members include Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet, each bringing a wealth of experience and expertise.

Background on Mission 3A

Mission 3A is a pioneering venture studio focused on scaling breakthrough companies across various sectors, with its healthcare division dedicated specifically to developing MedTech and AI solutions. The firm aims to address critical challenges in healthcare by enhancing accessibility, affordability, and operational efficiency. With seasoned operators and investors as partners, Mission 3A collaborates closely with startup founders to create impactful solutions in the ever-evolving healthcare landscape.

The New Advisory Board Members

Patrick Fisher

Patrick Fisher serves as the President of Global Orthopedics at Orthofix and has a storied career that includes key positions at Stryker and Wright Medical. His deep understanding of orthopedic innovation and strategy makes him an instrumental addition to the advisory board. Fisher's leadership is expected to provide valuable insights into commercial opportunities and help steer Mission 3A’s growth in orthopedic solutions.

Kevin Cordell

With extensive oversight of billion-dollar orthopedic and cardiovascular businesses, Kevin Cordell is known for launching innovations that set trends in the medical market. His contributions have significantly boosted shareholder value, notably with the $5.4 billion acquisition of Wright Medical by Stryker. Cordell's expertise will help identify strategic opportunities that align with Mission 3A’s vision of healthcare advancement.

Dr. Greg Berlet

Dr. Greg Berlet, an acknowledged thought leader and orthopedic surgeon, adds a clinical perspective to the advisory board. His career is marked by contributions to medical education and numerous peer-reviewed publications—over 150 scientific articles to date. His involvement will ensure that Mission 3A remains at the forefront of clinical insights and innovations in MedTech, particularly at the intersection of healthcare and artificial intelligence.

Strategic Vision

The formation of the Healthcare Advisory Board is part of Mission 3A's broader strategy to bolster its initiatives in scaling health startups that focus on improving patient outcomes and operational efficiency through advanced technologies. Andy Reid, Partner and COO of Mission 3A's Healthcare Portfolio, expressed enthusiasm over the new members, noting their combined experience in investment, commercialization, and clinical leadership. This strong coalition will provide the necessary guidance to navigate the complexities of the healthcare landscape and to foster the development of the next generation of healthcare solutions.

Conclusion

The establishment of the Healthcare Advisory Board marks a significant step towards Mission 3A’s goal of shaping the future of healthcare innovation. With experts like Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet at the helm, the organization is poised to make a substantial impact in the MedTech arena. This development is not just a win for Mission 3A but also for the healthcare industry, which stands to benefit from their insights and strategic guidance as it evolves in this digital age.

As healthcare technology continues to advance rapidly, the contributions of such esteemed professionals will be crucial in steering transformative initiatives that can pave the way toward a more efficient and effective healthcare system.